HOME

TheInfoList



OR:

Jian Zhou (; 1957 – March 1999) was a Chinese virologist and cancer researcher, who with fellow researcher
Ian Frazer Ian Hector Frazer (born 6 January 1953) is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute (Australia). Frazer and Jian Zhou developed and patented the basic technolo ...
, invented
Gardasil Gardasil is an HPV vaccine for use in the prevention of certain strains of human papillomavirus (HPV). Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledge ...
and
Cervarix Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases. These types also cause most HPV-induced ...
, the
vaccine A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified.
s for stimulating human immunological resistance to the
cervical cancer Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal ...
-inducing
human papilloma virus Human papillomavirus infection (HPV infection) is caused by a DNA virus from the '' Papillomaviridae'' family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. In some cases, an HPV infection persists and r ...
.


Early life and education

Zhou was born in 1957 in
Hangzhou Hangzhou ( or , ; , , Standard Chinese, Standard Mandarin pronunciation: ), also Chinese postal romanization, romanized as Hangchow, is the capital and most populous city of Zhejiang, China. It is located in the northwestern part of the prov ...
,
Zhejiang Zhejiang ( or , ; , also romanized as Chekiang) is an eastern, coastal province of the People's Republic of China. Its capital and largest city is Hangzhou, and other notable cities include Ningbo and Wenzhou. Zhejiang is bordered by Ji ...
, China. He was admitted to Wenzhou Medical College in 1977 and graduated 1982. His wife Xiao-Yi Sun (孙小依) was his classmate at the college. He subsequently earned a master's degree from
Zhejiang Medical University Zhejiang Medical University () was a former university in Hangzhou, Zhejiang Province, China. In 1998, was merged into Zhejiang University to become its Medical School. History In 1952–53, due to the Adjustment for University Colleges and Depa ...
, where he pursued his research interest in
HPV Human papillomavirus infection (HPV infection) is caused by a DNA virus from the ''Papillomaviridae'' family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. In some cases, an HPV infection persists and res ...
. He then earned his M.D. at Henan Medical University (now medical school of
Zhengzhou University Zhengzhou University (), colloquially known in Chinese as Zhèngdà () and abbreviated as ZZU is a public university located in Zhengzhou, Henan, China. Zhengzhou University is the largest university in China in terms of number of students (a ...
) and worked as a postdoctoral researcher at
Beijing Medical University } Beijing ( ; ; ), alternatively romanized as Peking ( ), is the capital of the People's Republic of China. It is the center of power and development of the country. Beijing is the world's most populous national capital city, with over 21 ...
, before moving to the
University of Cambridge , mottoeng = Literal: From here, light and sacred draughts. Non literal: From this place, we gain enlightenment and precious knowledge. , established = , other_name = The Chancellor, Masters and Schola ...
in 1988 to continue his research in cancer and virus.


HPV and Papilloma vaccine

Zhou met future research partner
Ian Frazer Ian Hector Frazer (born 6 January 1953) is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute (Australia). Frazer and Jian Zhou developed and patented the basic technolo ...
at the University of Cambridge in 1989, bonded by a mutual respect and willingness to push the limits of their research. The two considered the problem of developing a vaccine for HPV – a virus that cannot be cultured without living tissue. Frazer convinced Zhou to join him at the
University of Queensland , mottoeng = By means of knowledge and hard work , established = , endowment = A$224.3 million , budget = A$2.1 billion , type = Public research university , chancellor = Peter Varghese , vice_chancellor = Deborah Terry , city = B ...
,
Brisbane Brisbane ( ) is the capital and most populous city of the Australian state of Queensland, and the third-most populous city in Australia and Oceania, with a population of approximately 2.6 million. Brisbane lies at the centre of the South ...
, and in 1990 they began to use
molecular biology Molecular biology is the branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions. The study of chemical and phys ...
to synthesize particles
in vitro ''In vitro'' (meaning in glass, or ''in the glass'') studies are performed with microorganisms, cells, or biological molecules outside their normal biological context. Colloquially called " test-tube experiments", these studies in biology a ...
that could mimic the virus. In March 1991 Zhou's wife and fellow researcher, Xiao-Yi Sun, assembled by Zhou's instructions two
proteins Proteins are large biomolecules and macromolecules that comprise one or more long chains of amino acid residues. Proteins perform a vast array of functions within organisms, including catalysing metabolic reactions, DNA replication, respo ...
into a virus-like particle (VLP), resembling the HPV shell, from which
HPV vaccine Human papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HP ...
would ultimately be made. The vaccine completely protects unexposed women against four HPV strains responsible for 70% of cervical cancers, which kill about 250,000 women annually. Estimates of the contemporary global mortality rate have remained in the 190,000 to 300,000 range from 2000 to 2010
The 2007 WHO progress report
says that preventable cervical cancer "''was responsible in 2005 for up to 500,000 new cases, and up to 257,000 deaths, more than 90% in low- and middle-income countries''", but, "''According to WHO’s projections, deaths from cervical cancer will rise to 320,000 in 2015 and to 435,000 in 2030''" (p.4). These projections may be little effected by vaccination programs (anyway unlikely on cost grounds) because "''A reduction in cancer incidence and mortality might not be measurable before 10 to 30 years after the vaccine is introduced.''" (p.5). Other estimates of the problem's scale are broadly in agreement: * * *
Frazer and Zhou filed a
provisional patent Under United States patent law, a provisional application is a legal document filed in the United States Patent and Trademark Office (USPTO), that establishes an early filing date, but does not mature into an issued patent unless the applica ...
in June 1991 and began work on developing the vaccine within UQ. To finance clinical trials, Australian medical company CSL, and later Merck, were sold partial patents. (CSL has the exclusive license to sell Gardasil in New Zealand and Australia, Merck the license elsewhere.)
GlaxoSmithKline GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. GSK is the tent ...
independently used the same VLP-approach to develop Cervarix, under a later US patent, licensing Frazer's
intellectual property Intellectual property (IP) is a category of property that includes intangible creations of the human intellect. There are many types of intellectual property, and some countries recognize more than others. The best-known types are patents, co ...
in 2005.


Death

In March 1999, Zhou died of
hepatitis Hepatitis is inflammation of the liver tissue. Some people or animals with hepatitis have no symptoms, whereas others develop yellow discoloration of the skin and whites of the eyes ( jaundice), poor appetite, vomiting, tiredness, abdominal ...
, a disease he had contracted as a young man in China. He was survived by his wife Xiao-Yi Sun and son Andreas Zhou. In 2008, Zhou's contribution to his efforts in research, including his work with the
Gardasil Gardasil is an HPV vaccine for use in the prevention of certain strains of human papillomavirus (HPV). Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledge ...
vaccine, were formally recognised with a commemorative service attended by over 300 people, and included a written tribute from the
Australian Prime Minister The prime minister of Australia is the head of government of the Commonwealth of Australia. The prime minister heads the executive branch of the federal government of Australia and is also accountable to federal parliament under the princi ...
of the time,
Kevin Rudd Kevin Michael Rudd (born 21 September 1957) is an Australian former politician and diplomat who served as the 26th prime minister of Australia from 2007 to 2010 and again from June 2013 to September 2013, holding office as the leader of the ...
in
Brisbane Brisbane ( ) is the capital and most populous city of the Australian state of Queensland, and the third-most populous city in Australia and Oceania, with a population of approximately 2.6 million. Brisbane lies at the centre of the South ...
, Australia.


Published papers

* Zhou et al. “Increased Expression of Vaccinia Recombinant HVP 16 L1 and L2 ORF Proteins in Epithelium Cells Is Sufficient for Assembly of HVP Virion Like Particles”, ''J. Gen. Virology'', 1990, pp. 2185–2190, Vol. 71. * Zhou et al. “Increased Antibody Responses to Human Papilloma Virus Type 16 L1 Protein Expressed by Recombinant Vaccine Virus Lacking Serine Protease Inhibitor Genes”, ''Chemical Abstracts'', Nov. 5, 1990, Vol. 13, No. 19 * Zhou et al. “Human Pappilomavirus Type 16 Virions Produced by Recombinant Viccinia Virus”, Abstract from 1991 Papilloma Virus Workshop (Seattle, WA 1991) * J. Zhou, X.Y. Sun, D.J. Stenzel, I.H. Frazer, “Expression of Vaccinia Recombinant HPV 16 L1 and L2 ORF Proteins in Epithelial Cells”, 185 ''Journal of Virology'' 251 (1991), pp 251–257


References and notes


External links


the indispensable virus like particle
{{DEFAULTSORT:Zhou, Jian 1957 births 1999 deaths Biologists from Zhejiang Chinese immunologists Papillomavirus 20th-century Chinese physicians 20th-century Chinese scientists Wenzhou Medical College alumni Zhejiang University alumni Zhengzhou University alumni Medical academics at the University of Cambridge University of Queensland faculty University of Queensland Mayne Medical School alumni Chinese expatriates in Australia Deaths from hepatitis Physicians from Zhejiang Chinese virologists Cancer researchers